About OncoNano
OncoNano is a private company based in Dallas, Texas. It has reported $125,056,506 raised in four offerings on Form D since March 2018. Its chief executive is Brett Giroir.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | Oct 8, 2026 | $10,051,615of $15.0M target | 14 | $717K | EquityRule 506(b) | Form D ↗ |
| Apr 11, 2025 | Jun 2, 2025 | $12,698,061fully sold | 25 | $507K | Equity, OptionsRule 506(b) | Form D ↗ |
| Oct 15, 2020 | Oct 21, 2020amended Nov 3, 2021 | $68,407,469fully sold | 27 | $2.5M | EquityRule 506(b) | Form D/A ↗3 earlier filings |
| Mar 13, 2018 | Mar 28, 2018amended Apr 22, 2019 | $33,899,361of $35.3M target | 39 | $869K | Equity, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Total, four offerings | $125,056,506 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on OncoNano's Form D filed Oct 8, 2026.
Earlier filings also listed Melissa Paoloni (executive officer, last listed Jun 2025), Matthew Head (chief financial officer, last listed Jun 2025), Kartik Krishnan (executive officer and director, last listed Jun 2025), Yumin Qiu (director, last listed Nov 2021), Martin Driscoll (ceo and director, last listed Nov 2021), Alvaro Guillem (director, last listed Nov 2021), Ravi Srinivasan (president and ceo, director, last listed Apr 2019) and Paritosh Dhawale (director, last listed Apr 2019).